Back to SYRE

Janus Henderson Group Ltd. → SYRE

Janus Henderson Group Ltd. SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
9
Latest value
$8.5M
Q3 2026
Peak value
$248.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$701K
Q4 2025$59.2M
Q1 2026$1.1M
Q1 2026$82.5M
Q1 2026$1.1M
Q1 2026$82.5M
Q3 2026$248.8M
Q3 2026$527K
Q3 2026$8.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$8.5M94.9K——
Q3 2026$527K5.9K——
Q3 2026$248.8M2.79M——
Q1 2026$82.5M1.63M——
Q1 2026$1.1M21.4K——
Q1 2026$82.5M1.63M——
Q1 2026$1.1M21.4K——
Q4 2025$59.2M1.81M——
Q4 2025$701K21.4K——

Other funds holding SYRE

Other Janus Henderson Group Ltd. positions

NVDA

NVIDIA CORPORATION

$15B
NVDA

NVIDIA CORPORATION

$13.2B
NVDA

NVIDIA CORPORATION

$12.4B
NVDA

NVIDIA CORPORATION

$12.4B
MSFT

MICROSOFT CORP

$11B
GOOGN

ALPHABET INC

$9B
MSFT

MICROSOFT CORP

$8.4B
MSFT

MICROSOFT CORP

$7.7B